IGF1 and atherosclerosis: In ApoE knockout models, supplementation of a stable IGF-1 analog stabilized plaque development by increasing vascular smooth muscle (VSMC) cell proliferation, suppressing inflammation-induced VSMC apoptosis, and increasing the cap to core ratio in early atherosclerosis.